These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13629491)

  • 1. Natural agglutinis in rat sera against cells of mouse tumors differing in their transplantability to pretreated rats.
    PIKOVSKI M; SCHLESINGER M
    Cancer Res; 1959 Feb; 19(2):227-32. PubMed ID: 13629491
    [No Abstract]   [Full Text] [Related]  

  • 2. The transplantability of strain-specific and nonspecific mouse tumors to pretreated rats.
    PIKOVSKI M; SCHLESINGER M
    Cancer Res; 1959 Feb; 19(2):222-6. PubMed ID: 13629490
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
    Zhang X; Wei H; Chen Q; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X; Wei H; Wang H; Tian Z
    Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immunity responses against EGFR-positive tumor cells induced by xenogeneic EGFR expressed in the yeast Pichia pastoris.
    Fang F; Chen P; Chen XC; Li J; Wen YJ; Wei YQ
    Int J Mol Med; 2009 Feb; 23(2):181-8. PubMed ID: 19148541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.
    Felicetti P; Mennecozzi M; Barucca A; Montgomery S; Orlandi F; Manova K; Houghton AN; Gregor PD; Concetti A; Venanzi FM
    Cytotherapy; 2007; 9(1):23-34. PubMed ID: 18236207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of normal and immune rabbit sera to different mouse cells.
    HOLECKOVA E; RYCHLIKOVA M; MOLOMUT N
    Neoplasma; 1961; 8():269-74. PubMed ID: 13715252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophoretic studies on the sera in albino rats immunized against the ascites tumors of rats treated with trichloroacetic acid].
    AIZAWA M; IRIE M; SUYAMA T
    Gan; 1956 Dec; 47(3-4):555-6. PubMed ID: 13415127
    [No Abstract]   [Full Text] [Related]  

  • 9. Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways.
    Cheng WF; Hung CF; Lee CN; Su YN; Chang MC; He L; Wu TC; Chen CA; Hsieh CY
    Eur J Immunol; 2004 Jul; 34(7):1892-900. PubMed ID: 15214037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to xenogenic antigens--a study in the mouse-to-rat system.
    Bersztel A; Lorant T; Björkland A; Johnsson C; Tufveson G
    Tissue Antigens; 2006 Dec; 68(6):483-8. PubMed ID: 17176438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune recognition and suppression of tumors.
    Hayakawa Y; Smyth MJ
    Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches using natural killer cells in cancer therapy.
    Suck G
    Semin Cancer Biol; 2006 Oct; 16(5):412-8. PubMed ID: 16914327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
    Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV
    Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sendai virus for cancer immunotherapy.
    Ueda Y; Hasegawa M; Yonemitsu Y
    Methods Mol Biol; 2009; 515():299-308. PubMed ID: 19378123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obese and lean Zucker rat sera on human and rat prostate cancer cells: implications in obesity-related prostate tumor biology.
    Lamarre NS; Ruggieri MR; Braverman AS; Gerstein MI; Mydlo JH
    Urology; 2007 Jan; 69(1):191-5. PubMed ID: 17270657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors.
    Ariga T; Suetake K; Nakane M; Kubota M; Usuki S; Kawashima I; Yu RK
    Neurosignals; 2008; 16(2-3):226-34. PubMed ID: 18253060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer dendritic cells: IKDC and the others.
    Bonmort M; Dalod M; Mignot G; Ullrich E; Chaput N; Zitvogel L
    Curr Opin Immunol; 2008 Oct; 20(5):558-65. PubMed ID: 18554881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
    Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
    J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.